Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 14/20 | 0.54 |
| ▸ | MAOA | P21397 | 1/20 | 0.54 |
| ▸ | MAOB | P27338 | 1/20 | 0.54 |
| ▸ | APP | P05067 | 4/20 | 0.52 |
| ▸ | NQO2 | P16083 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.41 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.41 |
| ▸ | KDM1A | O60341 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8733107 | 0.88 | NR1H2 (0.39) | CYP19A1MAOAMAOBAPPMEN1 | |
| SCHEMBL8733104 | 0.88 | NR1H2 (0.39) | CYP19A1MAOAMAOBAPPMEN1 | |
| SCHEMBL1172568 | 0.85 | MEN1 (0.50) | APPMEN1NPC1MAPTRAB9A | |
| Ethane SCHEMBL3211361 | 0.83 | MEN1 (0.47) | APPMEN1NPC1MAPTRAB9A | |
| SCHEMBL27043327 | 0.83 | APP (0.54) | CYP19A1MAOAMAOBAPPNQO2 | |
| SCHEMBL11244660 | 0.80 | CYP19A1 (0.78) | CYP19A1MAOAMAOBAPPNQO2 | |
| SCHEMBL10459178 | 0.80 | CYP19A1 (0.78) | CYP19A1MAOAMAOBAPPNQO2 | |
| SCHEMBL7646748 | 0.80 | CYP19A1 (0.78) | CYP19A1MAOAMAOBAPPNQO2 | |
| SCHEMBL9680840 | 0.80 | CYP19A1 (0.78) | CYP19A1MAOAMAOBAPPNQO2 | |
| SCHEMBL65443 | 0.80 | CYP19A1 (0.78) | CYP19A1MAOAMAOBAPPNQO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8785001-B2 | Organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2014-07-22 | — | — | US | disclosed |
| US-8304095-B2 | Organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2012-11-06 | — | — | US | disclosed |
| US-8207526-B2 | Organic EL device | IDEMITSU KOSAN CO., LTD. (JP) | 2012-06-26 | — | — | US | disclosed |
| US-20100314644-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2010-12-16 | — | — | US | disclosed |
| US-20100044689-A1 | ORGANIC EL DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2010-02-25 | — | — | US | disclosed |
| US-20080297037-A1 | Organic Electroluminescent Devices | MERCK PATENT GMBH (DE) | 2008-12-04 | — | — | US | disclosed |
| US-20080272693-A1 | Organic Electroluminescent Devices | MERCK PATENT GMBH (DE) | 2008-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080272693-A1 | Organic Electroluminescent Devices | EML4, MT-ND4L, EPCAM | CYP19A1 3419/4885MAOA 969/4885MAOB 344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.